Cite
HARVARD Citation
Mavoko, H. et al. (2017). Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. Lancet. 5 (1), pp. e60-e68. [Online].